Literature DB >> 2647330

Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells.

J Varani1, B L Riser, L A Hughes, T E Carey, S E Fligiel, V M Dixit.   

Abstract

Previous studies have shown that thrombospondin (TSP) is an adhesion factor for some human tumor cells. The previous studies have shown further that tumor cells which utilize TSP as an adhesion factor also synthesize it. This study continues the effort to understand how TSP production and expression are regulated in human tumor cells and the consequences of this for the cells. It is shown that differences among cell lines in their capacity to biosynthesize TSP are associated with differences in TSP specific mRNA levels. This indicates that biosynthesis is regulated at the transcriptional level. There is also a direct relationship between TSP biosynthesis and secretion into the culture medium and expression at the cell surface. The cells which are the most biosynthetically active secrete amounts of TSP into the culture medium that are sufficient to elicit a detectable response in the cell-substrate adhesion assay. The kinetics of TSP secretion by these cells are in accord with the kinetics of attachment and spreading of the same cells in the absence of exogenous adhesion factors. These data are consistent with the idea that endogenously produced TSP promotes the adhesion of the cells which synthesize it in an autocrine manner.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647330     DOI: 10.1007/bf01753679

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  30 in total

1.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

2.  Granular pneumocytes in primary culture secrete several major components of the extracellular matrix.

Authors:  H Sage; F M Farin; G E Striker; A B Fisher
Journal:  Biochemistry       Date:  1983-04-26       Impact factor: 3.162

3.  Effects of anti-thrombospondin monoclonal antibodies on the agglutination of erythrocytes and fixed, activated platelets by purified thrombospondin.

Authors:  V M Dixit; D M Haverstick; K M O'Rourke; S W Hennessy; G A Grant; S A Santoro; W A Frazier
Journal:  Biochemistry       Date:  1985-07-30       Impact factor: 3.162

4.  Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion.

Authors:  R L Silverstein; R L Nachman
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

5.  Products of cells cultured from gliomas. IV. Extracellular matrix proteins of gliomas.

Authors:  P E McKeever; S E Fligiel; J Varani; J L Hudson; D Smith; R L Castle; J P McCoy
Journal:  Int J Cancer       Date:  1986-06-15       Impact factor: 7.396

6.  Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin.

Authors:  J McPherson; H Sage; P Bornstein
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

7.  Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin.

Authors:  V M Dixit; S W Hennessy; G A Grant; P Rotwein; W A Frazier
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Thrombospondin-induced attachment and spreading of human squamous carcinoma cells.

Authors:  J Varani; V M Dixit; S E Fligiel; P E McKeever; T E Carey
Journal:  Exp Cell Res       Date:  1986-12       Impact factor: 3.905

9.  Isolation of the thrombospondin membrane receptor.

Authors:  A S Asch; J Barnwell; R L Silverstein; R L Nachman
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

10.  Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing.

Authors:  N J Galvin; V M Dixit; K M O'Rourke; S A Santoro; G A Grant; W A Frazier
Journal:  J Cell Biol       Date:  1985-10       Impact factor: 10.539

View more
  14 in total

Review 1.  CD47: a new target in cardiovascular therapy.

Authors:  Jeff S Isenberg; David D Roberts; William A Frazier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-10       Impact factor: 8.311

Review 2.  LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.

Authors:  Anna P Lillis; Lauren B Van Duyn; Joanne E Murphy-Ullrich; Dudley K Strickland
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

3.  Role of thrombospondin in the adhesion of human endothelial cells in primary culture.

Authors:  V Morandi; F Fauvel-Lafeve; C Legrand; Y J Legrand
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

4.  Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.

Authors:  M Streit; P Velasco; L F Brown; M Skobe; L Richard; L Riccardi; J Lawler; M Detmar
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

5.  Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours.

Authors:  M Patey; B Delemer; G Bellon; L Martiny; M Pluot; B Haye
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

6.  Expression of thrombospondin-1 in human hepatocarcinoma cell lines and its regulation by transcription factor Jun/AP-1.

Authors:  S A Kim; S J Um; J H Kang; K J Hong
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

7.  Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.

Authors:  Eui Jin Suh; Mohammad Humayun Kabir; Un Beom Kang; Jong Won Lee; Jonghan Yu; Dong Young Noh; Cheolju Lee
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

8.  Thrombospondin-1 is a transcriptional repression target of PRMT6.

Authors:  Jonathan Michaud-Levesque; Stéphane Richard
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

9.  Matricellular proteins: a sticky affair with cancers.

Authors:  Han Chung Chong; Chek Kun Tan; Royston-Luke Huang; Nguan Soon Tan
Journal:  J Oncol       Date:  2012-02-09       Impact factor: 4.375

10.  Matrix-bound thrombospondin promotes angiogenesis in vitro.

Authors:  R F Nicosia; G P Tuszynski
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.